Background Necrotizing enterocolitis (NEC) is one of the leading causes of death in premature infants. To determine the factors present in the disease that lead to increased morbidity and mortality, manipulation of variables that are shown to have a positive response has been tested using various animal models. Testing and manipulation of these variables are unwarranted in humans due to regulatory health standards.
Methods The purpose of this review is to provide an update to previous summaries that determine the significance of animal models in studying the mechanisms of NEC. A large variety of animal models including rats, mice, rabbits, piglets, nonhuman primates, and quails have been described in literature. We reviewed the reported animal models of NEC and examined the pros and cons of the various models as well as the scientific question addressed.
Results The animals used in these experiments were subject to gavage feeding, hypoxia, hypothermia, oxygen perfusion, and other methods to induce the disease state. Each of these models has been utilized to show the effects of NEC on the premature, undeveloped gut in animals to find a correlation to the disease state present in humans. We found specific advantages and disadvantages for each model.
Conclusions Recent advances in our understanding of NEC and the ongoing therapeutic strategy developments underscore the importance of animal models for this disease.
- animal research
- basic science
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Necrotizing enterocolitis (NEC) is a devastating disease affecting premature infants. Approximately 10% of infants born weighing less than 1500 g will develop the disease, with mortality rates for affected infants being as high as 20%–30%.1 Mechanisms leading to the development of NEC are not completely understood, which makes the study of this disease difficult.2 Although the exact pathophysiology of NEC is not fully understood, most experts agree that its etiology is multifactorial. It is felt that impaired gastrointestinal (GI) motility, intestinal barrier dysfunction, decreased digestive ability, poor circulatory regulation, intestinal microbial overgrowth, and immature immune defenses predispose premature newborns to intestinal injury leading to NEC.3 4
Naturally, development of robust animal models to aid in the study of this disease process is of critical importance. Traditionally, gavage formula fed/hypoxia/hypothermia models have been used for induction of NEC in mice, rats, and piglets. Asphyxia has been shown to hold a crucial role in the development of NEC because formula and bacterial exposure without asphyxia typically do not result in the phenotypical injury pattern seen in NEC.2 Another significant variable that has been manipulated in various models is the removal of breast milk. It is well known that breast milk contains large amounts of immunoglobulin A (IgA), smaller amounts of Immunoglobulin G (IgG), active lymphocytes and macrophages, and specific antibodies against many types of microorganisms.3 Barlow et al4 theorized that without the passive immunity and intestinal flora control of breast milk, the enteric mucous barrier will be destroyed, leading to a pathologic cascade characterizing NEC.4
To induce intestinal damage and microbial dysbiosis, pathogenic bacteria can be administered to disrupt the intestinal epithelial barrier leading to an inflammatory response and translocation of pathogens.5 Although this explains the presence of intestinal epithelial disruption that characterizes NEC, it does not explain the presence of intestinal necrosis that is seen in patients with this disease, nor can this explanation readily reconcile the observation that most patients who develop NEC do not actually have an antecedent ischemic event.6
The clinical NEC seen in different animal models resembles NEC presented in human patients. Robust animal models closely resembling human disease are critical to test biochemical pathways, cell receptors, enteral nourishment, mechanisms of direct bowel injury, and studies that cannot ethically be conducted in humans. Animal models of NEC utilizing rats, mice, nonhuman primates, and piglets have been used to study the pathogenesis of NEC.
The advantages and disadvantages to use animal models are to be discussed in further detail. Because of the differences in size, genetic manipulation, cost of use, and preterm viability, each animal model can be examined to highlight the beneficial aspects of how NEC can be modeled.
The rat model has been used most commonly for NEC analysis due to the similarity to human preterm infants. NEC mainly affects premature and low birthweight neonates and is characterized by ischemic necrosis of the bowel wall frequently leading to perforation and death.3 As such, neonatal rats can be useful models for comparison due to their level of bowel immaturity at day 21 of gestation. One of the earliest studies to use rats concluded that the gut flora and absence of breast milk were suggested to play important roles in NEC pathogenesis.7 In Barlow’s model, a formula was developed which simulated rat breast milk and could be mixed with a bacterial contaminant. In this model, the pups are removed immediately after Cesarian section and are placed in an incubator, with avoidance of breast feeding.8 The stressors used to induce a NEC like state in the animal models includes hypoxia, hypothermia, addition of a lipopolysaccharide (LPS) and hyperosmolar formula during the course of feeding throughout a week long experiment (figure 1). In this model, a formula is given four times per day with an increasing caloric intake each day of the week.8 At the end of the protocol, or when rat pups have clinical signs of NEC, intestines are harvested and histologically graded for intestinal injury 0–4 with lessions greater than 2 being considered as NEC (figure 2).
Several laboratories have modified this formula feeding/hypoxia/hypothermia rat NEC model using additional elements to help induce NEC. One model has administered commensal bacteria found in stool, whereas others have tried different types of bacteria.7 Some researchers introduced Cronobacter sakazakii (CS), formerly known as Enterobacter sakazakii, a bacteria that was reported to be associated with NEC, to the formula-feeding/hypoxia rat NEC model.7
Rat models are an attractive option when studying NEC due to their low cost, preterm viability post-Cesarian section, and resilience to common stressors used to induce the disease.9 One disadvantage seen is the lack of commercial antibodies produced to target selected receptors involved in NEC. Another disadvantage is that rats are highly tolerant to different types of bacteria and it can be difficult to achieve success when attempting to induce disease. Last but not least, another major drawback is the lack of genetic diversity found in rats compared with other species of rodents.7
Using this model, many promising preventative and therapeutic interventions have been tested such as administration of probiotics, growth factors, stem cells, human milk oligosaccharides, tumor necrosis factor (TNF) blockers, and various antioxidants.9 To date, we found more than 400 papers that have used the rat model with or without modifications from the original description.
One of the major challenges and limitations of various animal models is that humans have an inherently different pattern of gene expression and therefore immune response to the development of NEC. In addition to this limitation, mice are also different due to their size compared with newborn rats or piglets. However, despite these limitation, mouse models have produced greater insights into the significance of prematurity in animals who develop NEC.7
Humanized mouse models have initiated an area of interest for modeling NEC through genetic manipulation. Humanized mice can be defined as animals that are genetically manipulated to express human genes.10 This model also relies on the use of hyperosmolar formula gavage feeds, hypoxia, and hypothermia. The addition of LPS to increase the incidence of NEC is variable across the published literature.
The most useful advantage of the mouse model comes from the ability to monitor and manipulate genetic variability and the use of transgenic animals to compare knockout (KO) mice to wild-type. The advantage of a humanized mouse model is the interrogation of human tissue while examining the progression of the disease.7 With this ability, the complex biological processes can be appreciated better in an attempt to model human neonates. For example, KO and transgenic (TG) models have been used to test the role of different growth factors in the prevention and treatment of NEC such as epidermal growth factor (EGF) and heparin-binding EGF-like growth factor (HB-EGF).11 12
HB-EGF TG mice were designed to specifically overexpress the human HB- EGF precursor (proHB-EGF) in the intestine.11 Using this model, the investigators were able to demonstrate that decreased endogenous HB-EGF expression predisposed the intestines to the development of NEC and the opposite being true for HB-EGF TG mice that overexpressed HB-EGF.11
The advantages of this model lie in the ability to easily breed mice, the ability to genetically alter lines, and the cost–benefit of using a smaller animal model compared with the other animal models. On the other hand, the smaller size of the pups at birth predisposes them to a increased rate of complications. The mouse pups are more difficult to handle and gavage feed with formula through an orogastric catheter compared with rats.
Compared with rodents, piglets share a high degree of anatomical, developmental, nutritional, and physiological similarity to the GI tract of humans.7 The piglet is therefore a good model for studies looking at pathogenesis of NEC, evaluation of specific feeding regimens, preclinical drug studies for prevention and potential therapy, as well as for the development of radiological diagnostic methods.7 During the neonatal period, protein deposition is very rapid, and owing to similarities of postnatal nutrition and intestinal development to humans, the piglet can be viewed as an accelerated model of postnatal growth and development.13 In addition, the piglet model is also appropriate for modeling other biological systems that may have an impact on the development of NEC such as liver function and metabolism due to its similarity with human systems.13
Generally, with small variations, the model involves piglets that are delivered by C-section at 90% term. Following birth, preterm piglets go through a period of natural hypoxia/hypothermia, and then are formula fed to induce injury.14 A variation uses total parental nutrition at birth followed by a transition to enteral formula feeds on the second day of life.9 15 16 Many investigators have used variations of this model as outlined in table 1.
Cohen et al17 described a model in which newborn piglets were subjected to a hypoxic insult for 30 min and hypothermic stress (core temperature reduced to 35°C for 30 min). After 3–4 days, approximately half of the animals developed histological changes that resembled NEC. Other investigators induced NEC through a combination of cow-based formula and ischemia/reperfusion such as the model described by Crissinger et al18 or by means of administered isosmolar acidified casein solution into intestinal segments of 1day-old piglets.19
All these reported variations of the piglet model serve to underline the importance of this model to study the pathogenesis of NEC.
Gurien et al20 evaluated the protective role of Lactococcus lactis against NEC using a rabbit model of NEC. In their description, 2-day-old preterm New Zealand white rabbit pups were gavage fed and given CS in addition to oral ranitidine and indomethacin after performing an anal blockage using adhesive tape. The anal blockage was intended to simulate the poor intestinal function and dysmotility of preterm neonates. Bozeman et al21 provided evidence that in this model the incidence of NEC increased with the duration and completeness of the anal blockage. Their model is similar to that in research of Gurien et al20 and utilized premature Csection delivered rabbits.
To examine the clinical applicability of Doppler sonography in a rabbit model of NEC, Choi et al22 induced experimental NEC using a combination of endotoxin, hypoxia, and cold stress.
Reduced oxygen to the small intestine induces mucosal injury and may contribute to neonatal NEC. Since little is known about the relationship between fetal hypoxia and GI motility, Sase et al23 assessed the potential effects using a rabbit model. These experiments gave insight into the GI motility, proving that it was significantly decreased by maternal hypoxia during the last third of gestation. It also highlighted that hypoxia-induced reduction in GI motility might contribute to neonatal NEC.
Miller et al24 reproduced NEC in rabbits by means of transmural injection of intestinal loops with an acidified solution of casein and calcium gluconate, mimicking the luminal milieu of afflicted neonates. Using this model, they demonstrated that NEC could be established by a luminal insult that caused local generation of free radicals and exaggerated release of prostaglandins and leukotrienes.24
Predominant enterobacteria from infants with NEC was examined for detecting unusual ability of fermenting lactose by Carbonaro et al.25 One such isolate, a Klebsiella pneumoniae strain, partially induced lactose operon expression in tryptone containing media, and was pathogenic in a rabbit ileal loop model for NEC. The results of these studies on the intraluminal biochemistry of infants with NEC support the hypothesis that an increased ability for lactose fermentation may be a bacterial pathogenic trait with respect to NEC.25 Many investigators have used variations of this model as outlined in table 2.
The quail model has been used in studies evaluating the role of bacteria in NEC. Development of cecal NEC-like lesions in quails requires the combination of two major factors that are present in preterm human infants: lactose in diet and colonization by lactose-fermenting bacteria. Experimental infection of germ-free quails with either Clostridium butyricum (CB) strains (monobiotic quails) or fecal specimens (polybiotic quails), both originating from preterm infants with NEC, reproduced many aspects of the pathology of NEC, such as thickening of the cecal wall with gas cysts, hemorrhagic ulcerations, necrotic areas, and intestinal pneumatosis.26 This model allowed the study of the role of bacterial strains involved in NEC in gnotobiotic quails as the experimental model. This model looked at Clostridia species, and demonstrated that this species were strongly implicated in NEC through excessive production of butyric acid as a result of colonic lactose fermentation.26 This model also served to understand the protective role of bifidobacteria through a decrease in clostridial populations and in butyric acid. Oligofructose dietary supplementation was shown to enhance the effect with an increase in the bifidobacterial level and consequently a greater decrease in clostridia, as described in table 3.27
In addition, innoculation of germ-free quails with bacteria associated with NEC have improved our understanding of the inducible nitric oxide synthase (iNOS) pathway activation prior to the development of macroscopic lesions in NEC.28
Nonhuman primate model
Though not as common, nonhuman primates have been utilized as models to examine the disease progression of NEC. Nonhuman primate models most closely resemble human disease states because of their homology in several organ systems, specifically seen in regard to their gastrointestinal development.13
Namachivayam et al29 described a NEC model using premature baboons, delivered via C-section at 125 days gestation, which was equivalent to a 27-week gestation human. The baboons were treated with mechanical ventilation, antibiotics, enteral feeds, and other necessary treatments similar to those provided to a neonate with sepsis. In this model, intravenous fluids were initiated at birth through a central line and parenteral nutrition was started at 24 hours. Enteral feeds were initiated after day 5 using a primate or human infant formula. Outcomes were compared that showed a difference in the transforming growth factor-beta expression in premature intestines during NEC.29
However, the main drawback with the use of nonhuman primates is the prohibitive cost in some instances. The expensive costs for housing and a longer lifespan and breeding period make these models less commonly observed, as explained in table 4.
Animal models of NEC have been around for a long time and they are of significant value to help us better understand the pathogenesis of NEC. Without them, our current understanding of pathways that lead to NEC would be very limited. These models have helped identify a number of promising and novel strategies such as probiotics, growth factors, stem cells, and breast milk to reduce the burden of NEC. There are significant variabilities to each and every model whether it is related to the animal size, genetic variability, or the protocol used to generate the model. However, they each have distinct advantages and drawbacks. As there is no “gold standard” animal model for the study of NEC, our paper highlights the importance of using animal models that are appropriate to answer the specific scientific question. We found that the most commonly used model remained the rat pup one, mainly due to its low cost, larger size of the pups and ease to learn and reproduce. As many authors have emphasized, there is a significant need for research and further development and funding in the field of NEC.
Contributors RA is responsible for the concept, design, and critical editing of the manuscript. MYS and PGV are responsible drafting of the manuscript and literature review. KF is responsible for the revision of the manuscript and literature review.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval It's not required for this review article.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement No data are available. Not applicable.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.